US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 2.720
  • +0.070+2.64%
Close Nov 27 16:00 ET
  • 2.730
  • +0.010+0.37%
Post 19:36 ET
174.73MMarket Cap-1754P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inozyme Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Inozyme Pharma Earnings Reports

  • Inozyme Pharma | 10-Q: Q3 2024 Earnings Report

    Nov 5 08:36 ET

  • Inozyme Pharma | 8-K: Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights

    Nov 5 08:36 ET

  • Inozyme Pharma | 10-Q: Q2 2024 Earnings Report

    Aug 6 08:43 ET

  • Inozyme Pharma | 8-K: Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights

    Aug 6 08:43 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data